07/09/2025 05:17
Sinovac Shareholders Vote to Remove Current Directors and Elect SAIF Partners Nominees to Board at Special Meeting

SAIF Partners IV L.P., (“SAIF Partners”, “we” or “us”), today announced that Sinovac Biotech Ltd. (“Sinovac” or the “Company”) shareholders voted to approve SAIF Partners’ proposals to remove the Company’s incumbent directors and to elect SAIF Partners’ slate of ten highly qualified director nominees to the Board of Directors (the “Board”) at Sinovac’s Special Meeting of Shareholders (the “Special Meeting”). On July 8, 2025, at 8:00 p.m. Atlantic Standard Time, Sinovac’s incumbent Chairman Ch...

06/18/2025 07:00
Americhem Aligns European Region Under Global Brand

Americhem Inc., a global leader in polymer solutions, has unified its European operations under the Americhem brand—streamlining customer experience and reinforcing alignment across global quality and manufacturing standards. “This move simplifies how we scale and serve,” said CEO John Richard. “One brand delivers clarity, consistency, and confidence.” The Denmark site supports Americhem’s healthcare strategy, producing ISO 13485 compounds for hearing aids, surgical tools, and drug delivery...

Agence France-Presse at the International Journalism Festival in Perugia

At the International Journalism Festival in Perugia, Italy, from April 9 to 13, 2025, Agence France-Presse (AFP) will be at the center of key discussions shaping the future of the profession. Five AFP journalists will participate in six high-profile panels addressing some of the most pressing challenges in modern journalism. This festival, one of the most significant annual events in the field, offers an essential platform for global media leaders, reporters, and scholars to engage in critical conversations about journalism’s evolving landscape.

At the International Journalism Festival in Perugia, Italy, from April 9 to 13, 2025, Agence France-Presse (AFP) will be at the center of key discussions shaping the future of the profession. Five AFP journalists will participate in six high-profile panels addressing some of the most pressing challenges in modern journalism. This festival, one of the most significant annual events in the field, offers an essential platform for global media leaders, reporters, and scholars to engage in critical conversations about journalism’s evolving landscape.
Anglais
06/18/2025 07:59
Ohmium International Appoints Veteran Energy Sector Leader as New CEO to Accelerate Global Growth and Scale

Ohmium International, a leading manufacturer of advanced PEM hydrogen electrolyzers, announced the appointment of Dr. Markus Tacke as its new CEO, effective July 1, 2025. With over 22 years of experience at Siemens and a proven track record in the renewable energy sector, Dr. Tacke will drive Ohmium's global expansion and commercialization of its next-generation green hydrogen solutions. Dr. Tacke has a history of growing companies in energy, infrastructure, manufacturing, and technology. His...

06/23/2025 10:00
IFF Opens New State-of-the-art Office in Hyderabad, India

IFF (NYSE: IFF)--a global leader in flavors, fragrances, food ingredients, health and biosciences—has officially relocated its Global Business Services (GBS) center in Hyderabad to a newly constructed, state-of-the-art facility. This move marks a significant step in IFF’s strategy to drive operational excellence and innovation through agile corporate functions. The new 75,000 sq. ft. office located in Hyderabad’s prime financial district, is designed to accommodate up to 600 employees. It featu...

ChatEurope: Understanding Europe Has Never Been Easier

Where have rents increased the most in Europe? Who won the presidential election in Poland? What does the European rearmament plan entail? No need to search endlessly — ChatEurope now has the answers to all your questions about Europe.

Where have rents increased the most in Europe? Who won the presidential election in Poland? What does the European rearmament plan entail? No need to search endlessly — ChatEurope now has the answers to all your questions about Europe.
Anglais
06/18/2025 08:00
StrongPoint Launches RetailQ: Data-Driven Analytics Service for Grocery E-Commerce Fulfillment

StrongPoint, the grocery technology company, today announced the launch of RetailQ, an analytics service designed to help grocery retailers uncover real cost savings in their order picking operations. RetailQ is an analytics service that uses advanced digital simulation and virtual pick bots to help grocery retailers identify cost savings and improve efficiency in their in-store picking operations. By digitally modelling every step of the fulfillment process, RetailQ enables retailers to test...

07/07/2025 11:00
CorFlow Therapeutics Announces FDA Approval of the MOCA-II IDE Pivotal Trial to Validate a Novel Heart Attack Care Technology

CorFlow Therapeutics AG (CorFlow), a pioneering company in the field of cardiac care targeting microvascular disease, today announced that the U.S. Food & Drug Administration (FDA) has approved the company’s technology for investigational device exemption (IDE), which allows the pivotal clinical trial to begin at U.S. hospitals. CorFlow will now prepare these clinical trial sites to receive CorFlow systems, undergo training and begin enrolling patients being treated for heart attacks. The...

07/07/2025 11:00
NTT DATA Appoints Anne-Sophie Lotgering as Europe CEO

NTT DATA, a global leader in digital business and technology services, today announced the appointment of Anne-Sophie Lotgering as the new Chief Executive Officer for Europe at NTT DATA, Inc., effective 1 September 2025. Lotgering succeeds Chieri Kimura and will report directly to NTT DATA, Inc. President and Global CEO, Abhijit Dubey. She will also join NTT DATA, Inc.’s Executive Leadership Team. Lotgering brings over two decades of leadership experience in IT services and telecommunications...

06/23/2025 10:30
Compass Pathways Successfully Achieves Primary Endpoint in First Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced today the successful achievement of the primary endpoint in the ongoing Phase 3 COMP005 trial, the first of two Phase 3 trials evaluating COMP360, a synthetic, proprietary formulation of psilocybin, for treatment-resistant depression (TRD). The primary endpoint is the difference in change from baseline in the Montgomery-Åsberg Depression Rating Scale (MAD...